Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | GM-CSF | 165.0 | 55 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | GM-CSF | 100.0 | 69 | |
N2586 | JNK-IN-11 | 0.3 | uM | 3 | GM-CSF | 175.0 | 27 | ||||
RA2159 | 3 | GM-CSF | 183.5 | 54 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | GM-CSF | 192.0 | 55 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | GM-CSF | 159.0 | 61 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | GM-CSF | 196.0 | 71 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | GM-CSF | 195.5 | 72 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | GM-CSF | 147.5 | 58 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | GM-CSF | 165.0 | 51 | ||||
N2586 | 3 | GM-CSF | 191.0 | 80 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | GM-CSF | 171.0 | 58 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | GM-CSF | 156.0 | 55 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | GM-CSF | 168.0 | 57 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | GM-CSF | 182.0 | 51 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | GM-CSF | 187.0 | 54 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | GM-CSF | 157.0 | 56 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | GM-CSF | 209.0 | 64 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | GM-CSF | 216.0 | 42 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | GM-CSF | 180.0 | 64 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | GM-CSF | 216.0 | 52 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | GM-CSF | 213.5 | 62 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | GM-CSF | 188.0 | 68 | |
N2586 | IL-17A | 100 | ng/mL | 3 | GM-CSF | 214.0 | 57 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | GM-CSF | 204.5 | 64 |